Kaiser Permanente, Washington, United States
Disclosure information not submitted.
SW-2G - Addressing the threat of confounding in pharmacoepidemiology with innovative methods: Lessons from the FDA Sentinel Innovation Center
Sunday, August 24, 20255:15 PM - 6:45 PM ET
